Wired for What’s Next.
Reach your press release and disclosure targets.
Get more views with multimedia.
Track your results and refine your message.
Be the news everyone talks about.
Latest News
Today is March 28, 2024.
All times in Eastern Daylight Time.
-
Wolters Kluwer named Market Leader in BARC Score Financial Performance Management 2024NEW YORK--(BUSINESS WIRE)--Wolters Kluwer, a global leader in information, software, and services for professionals, today announces that its CCH® Tagetik expert solution has retained its leadershi... more »
-
Shields Health Solutions Earns Great Place To Work™ Certification for the Fourth Consecutive YearSTOUGHTON, Mass.--(BUSINESS WIRE)--Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, announced today that it is Great Place to Work-Certified™ for the f... more »
-
InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare ApplicationsVICTORIA, British Columbia--(BUSINESS WIRE)--IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), InterSystems, a creative data technology provider dedicated to helping custo... more »
-
領先的CDMO PCI Pharma Services發布了首份全面的ESG報告費城--(BUSINESS WIRE)--(美國商業資訊)-- PCI Pharma Services(簡稱「PCI」),是一家領先的全球合同開發和製造組織(以下簡稱 CDMO),已發布其首份 環境、社會和治理 ( 簡稱 ESG ) 報告 。該報告詳細介紹了PCI在可持續發展方面的多方面努力,展示了自2021年正式啟動該計劃以來至其2023財年所取得的進展,并制定了在多個方面持續進展的雄心勃... more »
-
Riassunto: PCI Pharma Services, una delle principali CDMO, pubblica un report completo sui problemi ESGFILADELFIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”), una delle principali società internazionali di sviluppo e produzione su contratto (CDMO, Contract Development & Manufacturing Organizat... more »
-
A PCI Pharma Services, líder em CDMO, lança seu primeiro relatório abrangente de ESGFILADÉLFIA--(BUSINESS WIRE)--A PCI Pharma Services, (“PCI”), uma das principais organizações globais de desenvolvimento e fabricação de contratos (CDMO), lançou seu primeiro Relatório Ambiental, So... more »
-
Führender CDMO PCI Pharma Services veröffentlicht ersten umfassenden ESG-BerichtPHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services („PCI“), ein weltweit führendes Unternehmen für Auftragsentwicklung und -herstellung (CDMO), hat seinen ersten Environmental, Social & Governa... more »
-
PCI Pharma Services, une CDMO de premier plan, publie son premier rapport ESG completPHILADELPHIE--(BUSINESS WIRE)--PCI Pharma Services (« PCI »), une organisation mondiale de développement et de fabrication sous contrat (CDMO) de premier plan, vient de publier l'édition inaugurale... more »
-
领先的合同开发和制造组织PCI Pharma Services发布首份综合ESG报告费城--(BUSINESS WIRE)--(美国商业资讯)-- 全球领先的合同开发和制造组织(CDMO) PCI Pharma Services(以下简称“PCI”)发布了其首份 环境、社会和治理(ESG)报告 。该报告详细概述了PCI多方面的可持续发展历程,展示了该计划自2021年正式启动至2023财年期间所取得的长足进步,并提出了在多个方面继续取得进展的宏伟目标。 该深度报告披露了PCI... more »
-
Marc Havercroft Appointed Senior Vice President of International Sales at WorkForce SoftwareLIVONIA, Mich.--(BUSINESS WIRE)--WorkForce Software, the #1 rated workforce management solution for large employers, is pleased to announce the appointment of Marc Havercroft as Senior Vice Preside... more »
-
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-m... more »
-
Mannatech Reports Financial Results for Fourth Quarter and Full Year 2023FLOWER MOUND, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial ... more »
-
Mythic Therapeutics Appoints George Eliades, Ph.D., as President and Chief Executive OfficerWALTHAM, Mass.--(BUSINESS WIRE)--Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatmen... more »
-
BOSTON--(BUSINESS WIRE)--Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kris... more »
-
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compens... more »